Saikaya announced a plan to become a wholly owned subsidiary of AFC-HD AMS Life Science through a share exchange. The share exchange ratio was announced as 10:3, and the theoretical share price was calculated at ¥262.
Saikaya formally announced its plan to become a wholly owned subsidiary of AFC-HD AMS Life Science through a share exchange. The announced share exchange ratio was 10:3 for Saikaya:AFC-HD.
AFC-HD’s closing share price on the 19th was ¥874, based on which Saikaya’s theoretical share price was calculated at ¥262. The share price has been moving toward the level implied by the share exchange ratio.
Saikaya was at the limit-down sell indication, and trading on the exchange continued.
The announcement indicates progress toward Saikaya becoming a wholly owned subsidiary of AFC-HD AMS Life Science through a share exchange.